Indian Journal of Pharmacology最新文献

筛选
英文 中文
Carpal tunnel syndrome ascribed to low-dose combined oral contraceptive pills. 腕管综合征归因于低剂量联合口服避孕药。
IF 2.4 4区 医学
Indian Journal of Pharmacology Pub Date : 2023-05-01 DOI: 10.4103/ijp.ijp_594_22
Deepthi Yedla, Sharmila Vijayan, Thirunavukkarasu Arun Babu
{"title":"Carpal tunnel syndrome ascribed to low-dose combined oral contraceptive pills.","authors":"Deepthi Yedla,&nbsp;Sharmila Vijayan,&nbsp;Thirunavukkarasu Arun Babu","doi":"10.4103/ijp.ijp_594_22","DOIUrl":"10.4103/ijp.ijp_594_22","url":null,"abstract":"<p><p>Carpal tunnel syndrome (CTS) is the most prevalent compressive focal mononeuropathy brought on by median nerve compression, and common manifestations include pain in the wrist joint, decreased sensations along the distribution of the median nerve, a reduction in two-point discrimination, nighttime awakening, and, in more advanced stages, thenar muscle wasting and weakening. CTS, although common, yet underreported adverse effects of oral contraceptives. We report a case of 21-year-old female who developed CTS after using low-dose combined oral contraceptive pills for irregular cycles with polycystic ovary disease.</p>","PeriodicalId":13490,"journal":{"name":"Indian Journal of Pharmacology","volume":null,"pages":null},"PeriodicalIF":2.4,"publicationDate":"2023-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10501542/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10262431","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Risperidone-induced respiratory depression in a neonate through breast milk. 利培酮通过母乳诱导新生儿呼吸抑制。
IF 2.4 4区 医学
Indian Journal of Pharmacology Pub Date : 2023-05-01 DOI: 10.4103/ijp.ijp_645_22
Rachna Pasi, Madhu Bhavana Appikatla, Thirunavukkarasu Arun Babu
{"title":"Risperidone-induced respiratory depression in a neonate through breast milk.","authors":"Rachna Pasi,&nbsp;Madhu Bhavana Appikatla,&nbsp;Thirunavukkarasu Arun Babu","doi":"10.4103/ijp.ijp_645_22","DOIUrl":"10.4103/ijp.ijp_645_22","url":null,"abstract":"<p><p>Risperidone is commonly used in postnatal mothers for depression and psychotic symptoms in spite of little data on its safety profile in neonates. It is reported previously that 6 mg/day can be used in mothers without having any untoward in breastfed neonates. Excretion of risperidone is dependent on the enzyme CYP2D6 whose activity varies as per individual phenotype. Maximum therapeutic levels are achieved at 2 h of administration of the drug. We are reporting a case of preterm breastfed neonate who presented with respiratory depression twice due to risperidone usage in its mother. This is the first reported case where 1 mg/day dosage of risperidone in nursing mother was associated with acute adverse effects such as respiratory depression in her neonate. The Naranjo Adverse Drug Reaction Probability Assessment Scale scored to 8 which suggests probable relation between the drug and its reaction in neonates. It underscores cautious use in mothers and close monitoring of neonates when risperidone is prescribed irrespective of dosage.</p>","PeriodicalId":13490,"journal":{"name":"Indian Journal of Pharmacology","volume":null,"pages":null},"PeriodicalIF":2.4,"publicationDate":"2023-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10501541/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10260821","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effect of intraperitoneal magnesium sulfate in the prevention of postoperative pain in daycare laparoscopic cholecystectomy - A prospective randomized controlled trial. 腹膜内硫酸镁预防日托腹腔镜胆囊切除术后疼痛的作用——一项前瞻性随机对照试验。
IF 2.4 4区 医学
Indian Journal of Pharmacology Pub Date : 2023-05-01 DOI: 10.4103/ijp.ijp_827_22
Gorle Chaitanya Sravanthi, Kishore Abuji, Shiv Lal Soni, Satish Subbiah Nagaraj, Akhilesh Sharma, Anudeep Jafra, Cherring Tandup, Kailash Chand Kurdia, Divya Dahiya
{"title":"Effect of intraperitoneal magnesium sulfate in the prevention of postoperative pain in daycare laparoscopic cholecystectomy - A prospective randomized controlled trial.","authors":"Gorle Chaitanya Sravanthi,&nbsp;Kishore Abuji,&nbsp;Shiv Lal Soni,&nbsp;Satish Subbiah Nagaraj,&nbsp;Akhilesh Sharma,&nbsp;Anudeep Jafra,&nbsp;Cherring Tandup,&nbsp;Kailash Chand Kurdia,&nbsp;Divya Dahiya","doi":"10.4103/ijp.ijp_827_22","DOIUrl":"10.4103/ijp.ijp_827_22","url":null,"abstract":"<p><p>This study evaluated the efficacy of intraperitoneal magnesium sulfate (MgSO<sub>4</sub>) in preventing postoperative pain after elective laparoscopic cholecystectomy (LC). It is a prospective, double-blinded, placebo-controlled, randomized trial which included 64 patients who underwent LC. Patients were equally randomized into Groups A and B. MgSO<sub>4</sub> and normal saline were instilled in subdiaphragmatic space in Groups A and B, respectively, after creating pneumoperitoneum and before starting dissection. The Visual analogue Scale (VAS) was used to determine postoperative pain. Patients who received intraperitoneal MgSO<sub>4</sub> had lower average VAS scores for the first 6 h postoperatively, and also, the time for the requirement of first analgesic was longer (3.6 ± 0.4 vs. 2.3 ± 1.0 h). The incidence of vomiting and the requirement for rescue antiemetic was also lower in Group A. Intraperitoneal instillation of MgSO<sub>4</sub> reduces postoperative pain and vomiting following elective LC without incurring additional side effects.</p>","PeriodicalId":13490,"journal":{"name":"Indian Journal of Pharmacology","volume":null,"pages":null},"PeriodicalIF":2.4,"publicationDate":"2023-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10501544/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10262427","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clinical trials for food - The gray areas: Developing countries' perspective. 食品临床试验——灰色地带:发展中国家的观点。
IF 2.4 4区 医学
Indian Journal of Pharmacology Pub Date : 2023-05-01 DOI: 10.4103/ijp.ijp_412_23
Praisy K Prabha, Ajay Prakash, Bikash Medhi
{"title":"Clinical trials for food - The gray areas: Developing countries' perspective.","authors":"Praisy K Prabha,&nbsp;Ajay Prakash,&nbsp;Bikash Medhi","doi":"10.4103/ijp.ijp_412_23","DOIUrl":"10.4103/ijp.ijp_412_23","url":null,"abstract":"","PeriodicalId":13490,"journal":{"name":"Indian Journal of Pharmacology","volume":null,"pages":null},"PeriodicalIF":2.4,"publicationDate":"2023-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10501540/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10260818","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Variation in normative values of major clinical biochemistry analytes in healthy reproductive-age women in India: A subset of data from a National Indian Council of Medical Research-Polycystic Ovary Syndrome task force study. 印度健康育龄妇女主要临床生物化学分析正常值的变化:来自印度国家医学研究委员会多囊卵巢综合征工作组研究的数据子集。
IF 2.4 4区 医学
Indian Journal of Pharmacology Pub Date : 2023-03-01 DOI: 10.4103/ijp.ijp_694_22
Mohd Ashraf Ganie, Subhankar Chowdhury, Vanita Suri, Beena Nitin Joshi, Prasanta Kumar Bhattacharya, Sarita Agarwal, Neena Malhotra, Rakesh Sahay, P K Jabbar, Roya Rozati, Amlin Shukla, Haroon Rashid, Rohina Bashir, Imtiyaz Wani, Abhilash Nair, Taruna Katyal Arora, Bharati Kulkarni
{"title":"Variation in normative values of major clinical biochemistry analytes in healthy reproductive-age women in India: A subset of data from a National Indian Council of Medical Research-Polycystic Ovary Syndrome task force study.","authors":"Mohd Ashraf Ganie,&nbsp;Subhankar Chowdhury,&nbsp;Vanita Suri,&nbsp;Beena Nitin Joshi,&nbsp;Prasanta Kumar Bhattacharya,&nbsp;Sarita Agarwal,&nbsp;Neena Malhotra,&nbsp;Rakesh Sahay,&nbsp;P K Jabbar,&nbsp;Roya Rozati,&nbsp;Amlin Shukla,&nbsp;Haroon Rashid,&nbsp;Rohina Bashir,&nbsp;Imtiyaz Wani,&nbsp;Abhilash Nair,&nbsp;Taruna Katyal Arora,&nbsp;Bharati Kulkarni","doi":"10.4103/ijp.ijp_694_22","DOIUrl":"https://doi.org/10.4103/ijp.ijp_694_22","url":null,"abstract":"<p><strong>Objectives: </strong>Clinical biochemistry reference intervals (RIs) play a crucial role in interpreting patient test results and making informed clinical decisions. Using data from an ongoing Indian Council of Medical Research-National task force study on healthy women, normative ranges for commonly analyzed biochemical analytes were established.</p><p><strong>Materials and methods: </strong>A.</p><p><p>total of 13,181 women of reproductive age (18-40 years) were recruited from different urban and rural regions of the country, of which 9898 women signed an informed consent were included. Among these, women having features of hyperandrogenism, menstrual cycle irregularities, and comorbidities were excluded. RIs of 22 analytes were computed in the remaining 938 women controls. To estimate the 95% range of the reference distribution, the limits of the 2.5<sup>th</sup> percentile and the 97.5<sup>th</sup> percentile were used in the study.</p><p><strong>Results: </strong>Mean ± standard deviation of age and body mass index of participants was 30.12 ± 6.32 years and 22.8 ± 3.36 kg/m<sup>2</sup> respectively. Centiles (2.5<sup>th</sup>-97.5<sup>th</sup>) of liver function parameters, lipid parameters, glycaemic parameters, and renal parameters are presented. No significant difference in analytes was observed in relation to the area of residence, and age groups except in albumin (P = 0.03). The distribution of most of the parameters was consistent with the various RI studies conducted in India as well as other countries.</p><p><strong>Conclusion: </strong>This is the first study generating biochemical RIs data among a large representative sample of healthy reproductive-age women recruited using a robust design across the country. The resource may serve as a reference range for common biochemical analytes for future in this age group.</p>","PeriodicalId":13490,"journal":{"name":"Indian Journal of Pharmacology","volume":null,"pages":null},"PeriodicalIF":2.4,"publicationDate":"2023-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10335651/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9776151","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Reporting of adverse events related to medical devices: A single-center experience from a tertiary care institute of national importance in India. 报告与医疗器械相关的不良事件:来自印度国家级重要三级医疗机构的单中心经验。
IF 2.4 4区 医学
Indian Journal of Pharmacology Pub Date : 2023-03-01 DOI: 10.4103/ijp.ijp_495_21
Bikash Ranjan Meher, Ashish Dash
{"title":"Reporting of adverse events related to medical devices: A single-center experience from a tertiary care institute of national importance in India.","authors":"Bikash Ranjan Meher,&nbsp;Ashish Dash","doi":"10.4103/ijp.ijp_495_21","DOIUrl":"https://doi.org/10.4103/ijp.ijp_495_21","url":null,"abstract":"<p><p>As frontline health workers, nursing professionals have a crucial role in reporting medical device-associated adverse events (MDAEs). A questionnaire-based study was carried out to evaluate the knowledge, attitude, and practice of senior nursing officers (SNOs), nursing officers (NOs), and nursing students (NSs) toward MDAE. The response rate of the survey was 84% (n = 134). The mean score of knowledge of SNOs, NOs, and NSs was 2.03 ± 0.92, 1.71 ± 0.96, and 1.52 ± 0.82, respectively (P = 0.9). A large proportion of study participants (97%) considered that the use of medical device could sometimes cause untoward occurrences and detecting and reporting those events will enhance the safety of patients. However, many of them (67%) have not reported it during clinical posting. The participants of this survey possessed limited knowledge of MDAE. However, their attitude toward MDAE was encouraging and a continuous training program may improve their knowledge regarding MDAE and enhance the reporting practice.</p>","PeriodicalId":13490,"journal":{"name":"Indian Journal of Pharmacology","volume":null,"pages":null},"PeriodicalIF":2.4,"publicationDate":"2023-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10335646/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9769724","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Do alternatives to animal experimentation replace preclinical research? 动物实验的替代品是否取代了临床前研究?
IF 2.4 4区 医学
Indian Journal of Pharmacology Pub Date : 2023-03-01 DOI: 10.4103/ijp.ijp_223_23
Vidya Mahalmani, Ajay Prakash, Bikash Medhi
{"title":"Do alternatives to animal experimentation replace preclinical research?","authors":"Vidya Mahalmani,&nbsp;Ajay Prakash,&nbsp;Bikash Medhi","doi":"10.4103/ijp.ijp_223_23","DOIUrl":"https://doi.org/10.4103/ijp.ijp_223_23","url":null,"abstract":"","PeriodicalId":13490,"journal":{"name":"Indian Journal of Pharmacology","volume":null,"pages":null},"PeriodicalIF":2.4,"publicationDate":"2023-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10335642/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9769721","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Proteome architecture of human-induced pluripotent stem cell-derived three-dimensional organoids as a tool for early diagnosis of neuronal disorders. 人类诱导的多能干细胞衍生的三维类器官的蛋白质组结构作为早期诊断神经疾病的工具。
IF 2.4 4区 医学
Indian Journal of Pharmacology Pub Date : 2023-03-01 DOI: 10.4103/ijp.ijp_56_23
R Negi, A Srivastava, A K Srivastava, Abhishek Pandeya, P Vatsa, U A Ansari, A B Pant
{"title":"Proteome architecture of human-induced pluripotent stem cell-derived three-dimensional organoids as a tool for early diagnosis of neuronal disorders.","authors":"R Negi,&nbsp;A Srivastava,&nbsp;A K Srivastava,&nbsp;Abhishek Pandeya,&nbsp;P Vatsa,&nbsp;U A Ansari,&nbsp;A B Pant","doi":"10.4103/ijp.ijp_56_23","DOIUrl":"https://doi.org/10.4103/ijp.ijp_56_23","url":null,"abstract":"<p><strong>Background and objectives: </strong>Induced pluripotent stem cells (iPSCs) derived three-dimensional (3D) model for rare neurodegenerative disorders such as amyotrophic lateral sclerosis (ALS) is emerging as a novel alternative to human diseased tissue to explore the disease etiology and potential drug discovery. In the interest of the same, we have generated a TDP-43-mutated human iPSCs (hiPSCs) derived 3D organoid model of ALS disease. The high-resolution mass spectrometry (MS)-based proteomic approach is used to explore the differential mechanism under disease conditions and the suitability of a 3D model to study the disease.</p><p><strong>Materials and methods: </strong>The hiPSCs cell line was procured from a commercial source, grown, and characterized following standard protocols. The mutation in hiPSCs was accomplished using CRISPR/Cas-9 technology and predesigned gRNA. The two groups of organoids were produced by normal and mutated hiPSCs and subjected to the whole proteomic profiling by high-resolution MS in two biological replicates with three technical replicas of each.</p><p><strong>Results: </strong>The proteomic analysis of normal and mutated organoids revealed the proteins associated with pathways of neurodegenerative disorders, proteasomes, autophagy, and hypoxia-inducible factor-1 signaling. Differential proteomic analysis revealed that the mutation in TDP-43 gene caused proteomic deregulation, which impaired protein quality mechanisms. Furthermore, this impairment may contribute to the generation of stress conditions that may ultimately lead to the development of ALS pathology.</p><p><strong>Conclusion: </strong>The developed 3D model represents the majority of candidate proteins and associated biological mechanisms altered in ALS disease. The study also offers novel protein targets that may uncloud the precise disease pathological mechanism and be considered for future diagnostic and therapeutic purposes for various neurodegenerative disorders.</p>","PeriodicalId":13490,"journal":{"name":"Indian Journal of Pharmacology","volume":null,"pages":null},"PeriodicalIF":2.4,"publicationDate":"2023-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10335645/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9769726","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
A clinical study on the pattern of antimicrobial drug use and drug resistance in patients with ventilator-associated pneumonia in a tertiary care hospital. 某三级医院呼吸机相关性肺炎患者抗菌药物使用及耐药模式的临床研究
IF 2.4 4区 医学
Indian Journal of Pharmacology Pub Date : 2023-03-01 DOI: 10.4103/ijp.ijp_759_21
Abisha Rezia, R Vijendra
{"title":"A clinical study on the pattern of antimicrobial drug use and drug resistance in patients with ventilator-associated pneumonia in a tertiary care hospital.","authors":"Abisha Rezia,&nbsp;R Vijendra","doi":"10.4103/ijp.ijp_759_21","DOIUrl":"https://doi.org/10.4103/ijp.ijp_759_21","url":null,"abstract":"<p><strong>Context: </strong>Ventilator-associated pneumonia (VAP) develops nearly in about one-third of the patients, 48 h after receiving mechanical ventilation. Common pathogens are Pseudomonas aeruginosa, Staphylococcus aureus, Acinetobacter spp., Klebsiella spp., Escherichia coli, Proteus spp., Enterobacter spp. and Enterococcus spp. including multidrug-resistant pathogens.</p><p><strong>Aim: </strong>The study aims to assess the pattern of antimicrobial drug use in VAP and to assess the etiological organisms and their drug sensitivity and resistance pattern.</p><p><strong>Settings and design: </strong>Study participants admitted to Kempegowda Institute of Medical Sciences Hospital and Research Centre, Bengaluru, and who developed VAP were included in this prospective observational study.</p><p><strong>Subjects and methods: </strong>Bronchial secretions were subjected to microbiological analysis. The etiological organisms, their drug sensitivity and resistance pattern, and the outcome of drug therapy were recorded. The clinical course of the study participants was monitored till either the resolution of pneumonia or the demise of the participant.</p><p><strong>Statistical analysis used: </strong>Qualitative data were analyzed using the Chi-square test or Fischer's exact test and quantitative data using the independent t-test.</p><p><strong>Results: </strong>Early VAP was seen in 91.7% and late VAP in 8.3% of the participants. The organisms isolated were S. aureus, Enterococcus spp., Acinetobacter spp., Klebsiella pneumoniae and P. aeruginosa. Majority of the study participants with early VAP (75%, n = 41) completely recovered from pneumonia and 80%, n = 4 participants with late VAP recovered completely.</p><p><strong>Conclusion: </strong>The organisms had a varied sensitivity and resistance pattern. The clinical outcome was multifactorial and its association with specific antimicrobial agents cannot be drawn.</p>","PeriodicalId":13490,"journal":{"name":"Indian Journal of Pharmacology","volume":null,"pages":null},"PeriodicalIF":2.4,"publicationDate":"2023-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10335647/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9776150","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Role of intravenous aspirin versus oral aspirin in the treatment of acute coronary syndrome: Answering a clinical query by systematic review and meta-analysis of randomized controlled trials. 静脉注射阿司匹林与口服阿司匹林在治疗急性冠脉综合征中的作用:通过随机对照试验的系统评价和荟萃分析回答临床问题。
IF 2.4 4区 医学
Indian Journal of Pharmacology Pub Date : 2023-03-01 DOI: 10.4103/ijp.ijp_1147_20
Hardeep Kaur, Phulen Sarma, Anusuya Bhattacharyya, Manojkumar Rohit, Manisha Prajapat, Subodh Kumar, Ajay Prakash, Bikash Medhi
{"title":"Role of intravenous aspirin versus oral aspirin in the treatment of acute coronary syndrome: Answering a clinical query by systematic review and meta-analysis of randomized controlled trials.","authors":"Hardeep Kaur,&nbsp;Phulen Sarma,&nbsp;Anusuya Bhattacharyya,&nbsp;Manojkumar Rohit,&nbsp;Manisha Prajapat,&nbsp;Subodh Kumar,&nbsp;Ajay Prakash,&nbsp;Bikash Medhi","doi":"10.4103/ijp.ijp_1147_20","DOIUrl":"https://doi.org/10.4103/ijp.ijp_1147_20","url":null,"abstract":"<p><strong>Background: </strong>Aspirin is indicated in the emergency management of acute coronary syndrome. However, oral aspirin has erratic bioavailability compared to i.v. formulation.</p><p><strong>Objective: </strong>The objective of this study was to evaluate the comparative efficacy and safety of intravenous (IV) and oral aspirin in acute coronary syndrome.</p><p><strong>Study design: </strong>This was a systematic review and meta-analysis.</p><p><strong>Results: </strong>Two randomized controlled trials were included. Compared to oral aspirin, lower platelet aggregability was seen with IV aspirin at 5 min and 20 min. Lower thromboxane B2 and lower platelet CD-62p levels were noted in the IV group; however, no significant difference was observed in terms of \"composite cardiovascular death, stroke, and myocardial infarction (MI) at 4-6 weeks,\" \"any cause mortality,\" \"cardiovascular mortality,\" \"occurrence of stroke,\" and \"occurrence of MI/reinfarction.\" However, no difference was noted in terms of the occurrence of serious adverse events.</p><p><strong>Conclusion: </strong>IV aspirin showed some advantages in terms of platelet aggregability biomarkers at 20 min and 1 week with comparable safety to oral aspirin. No difference was seen in terms of clinical outcomes (at 24 h, 7, and 30 days) and the occurrence of serious adverse events.</p>","PeriodicalId":13490,"journal":{"name":"Indian Journal of Pharmacology","volume":null,"pages":null},"PeriodicalIF":2.4,"publicationDate":"2023-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10335641/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9776154","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信